Magdalena Staniszewska, PhD – Head of SAB

Magdalena Staniszewska - Head of SAB

Magdalena Staniszewska, PhD, DSc

Co-founder, Chief R&D Officer, and Head of Scientific Advisory Board

Graduated from the Wrocław University of Technology – M.Sc., specialty: molecular biology and biocatalysis; PhD in biological sciences, specialty: immunochemistry at the Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences and post-doctoral degree in medical sciences, specialization in biochemistry. She completed a post-doctoral fellowship at Case Western Reserve University, Cleveland, OH and Harvard Medical School, Boston, MA, USA. Assistant Professor affiliated with the Catholic University of Lublin.

An expert in the field of eye diseases related to diabetes, aging, and genetic predispositions. Experienced initiator and leader of interdisciplinary research projects aimed at discovering the mechanisms of diseases and creating new therapeutic and diagnostic strategies of application importance.

Prof. Staniszewska has over 20 years of experience in R&D projects, managing high-specialized laboratories, and successful cooperation between the academic community and biotechnology industry gained in the world’s best scientific centers – Harvard Medical School, Boston, MA and CWRU, Cleveland, OH in the USA. Scientific achievements in basic science and translational research area that is supported by 50 publications and patents, including diagnostic methods for the examination and treatment of pathological blood vessels. Her scientific achievements include understanding the modification of proteins in diabetes, aging, and cancer, establishing the role of new genes leading to vision loss, as well as creating many research models for the development and testing of novel gene therapies and regenerative medicine strategies. Experienced public speaker, and co-author of a number of patents implemented, among others, by Novartis AG and numerous scientific publications.